methylprednisolone hemisuccinate has been researched along with Chronic Kidney Failure in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (40.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gluck, C; Hooper, DK; Koziell, A; Moodalbail, D; Okamura, D; Shah, L; Wallace, D; Zaritsky, JJ | 1 |
| Behnke, M; Kimball, PM; King, A; Kumar, D; McDougan, F; Sharma, A | 1 |
| Hennigar, R; Lohavichan, V; Tumlin, JA | 1 |
| Andersen, RC; O'Brien, TJ; Rao, KV | 1 |
| Ettenger, RB; Gradus, D | 1 |
1 review(s) available for methylprednisolone hemisuccinate and Chronic Kidney Failure
| Article | Year |
|---|---|
Renal transplantation in children.
Topics: Antilymphocyte Serum; Azathioprine; Blood Grouping and Crossmatching; Blood Transfusion; Child; Graft Rejection; Growth; Histocompatibility Antigens Class II; Histocompatibility Testing; HLA Antigens; HLA-DR Antigens; Humans; Immunosuppression Therapy; Kidney Failure, Chronic; Kidney Transplantation; Methylprednisolone Hemisuccinate; Prednisone; T-Lymphocytes; Tissue Donors | 1982 |
2 trial(s) available for methylprednisolone hemisuccinate and Chronic Kidney Failure
| Article | Year |
|---|---|
Perioperative Desensitization Improves Outcomes Among Crossmatch Positive Recipients of Deceased Donor Renal Transplants.
Topics: Adult; Antibodies; Antilymphocyte Serum; Cadaver; Cohort Studies; Delayed Graft Function; Desensitization, Immunologic; Female; Graft Rejection; Graft Survival; Histocompatibility Testing; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone Hemisuccinate; Middle Aged; Mycophenolic Acid; Perioperative Care; Plasmapheresis; Tacrolimus | 2016 |
Crescentic, proliferative IgA nephropathy: clinical and histological response to methylprednisolone and intravenous cyclophosphamide.
Topics: Adult; Anti-Inflammatory Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Injections, Intravenous; Kidney Failure, Chronic; Male; Methylprednisolone Hemisuccinate; Middle Aged; Outcome Assessment, Health Care; Prospective Studies; Pulse Therapy, Drug; Time Factors | 2003 |
2 other study(ies) available for methylprednisolone hemisuccinate and Chronic Kidney Failure
| Article | Year |
|---|---|
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
Topics: Allografts; Blood Component Removal; Child; Child, Preschool; Combined Modality Therapy; Creatinine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Infant; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lipoproteins, LDL; Male; Methylprednisolone Hemisuccinate; Proteinuria; Pulse Therapy, Drug; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2019 |
Successful renal transplantation in a patient with anaphylactic reaction to Solu-Medrol (methylprednisolone sodium succinate).
Topics: Adult; Anaphylaxis; Azathioprine; Dexamethasone; Humans; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Methylprednisolone Hemisuccinate; Skin Tests | 1982 |